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a b s t r a c t
The present study intended to evaluate the performance of chitosan-based scaffolds produced by
a particle aggregation method aimed to be used in tissue engineering applications addressing key issues
such as morphological characteristics, mechanical performance and in vivo behaviour. It is claimed that
the particle aggregation methodology may present several advantages, such as combine simultaneously
a high interconnectivity with high mechanical properties that are both critical for an in vivo successful
application. In order to evaluate these properties, micro-Computed Tomography (micro-CT) and Dy-
namical Mechanical Analysis (DMA) were applied. The herein proposed scaffolds present an interesting
morphology as assessed by micro-CT that generally seems to be adequate for the proposed applications.
At a mechanical level, DMA has shown that chitosan scaffolds have an elastic behaviour under dynamic
compression solicitation, being simultaneously mechanically stable in the wet state and exhibiting
a storage modulus of 4.21! 1.04 MPa at 1 Hz frequency. Furthermore, chitosan scaffolds were evaluated
in vivo using a rat muscle-pockets model for different implantation periods (1, 2 and 12 weeks). The
histological and immunohistochemistry results have demonstrated that chitosan scaffolds can provide
the required in vivo functionality. In addition, the scaffolds interconnectivity has been shown to be
favourable to the connective tissues ingrowth into the scaffolds and to promote the neo-vascularization
even in early stages of implantation. It is concluded that the proposed chitosan scaffolds produced by
particle aggregation method are suitable alternatives, being simultaneously mechanical stable and in vivo
biofunctional that might be used in load-bearing tissue engineering applications, including bone and
cartilage regeneration.
! 2008 Elsevier Ltd. All rights reserved.
1. Introduction
In tissue engineering, scaffolds are typically needed, both as
carriers for cells or biochemical factors, or as constructs providing
appropriate mechanical conditions. In general, the term scaffold is
used to describe all structures that are used to restore functionality
of an organ either permanently or temporarily [1]. An ideal scaffold
should have several characteristics as it has been comprehensively
reviewed in several papers [1,2], such as: (i) three-dimensional (3D)
and porous supports with an interconnected pore network for cell
growth and flow transport of nutrients and metabolic waste with
suitable surface chemistry for cell attachment, proliferation, and
differentiation; (ii) mechanical properties adequate to the tissues at
the site of implantation and (iii) biocompatibility and bio-
degradability with a controllable degradation and resorption rate to
match cell/tissue growth in vitro and in vivo.
When considering the main aimed applications, it is not sur-
prising that there is a wide range of scaffolds, including porous
scaffolds that allow for cell adhesion, and provide biological func-
tions [1,3]. In fact, from a mechanical point of view, scaffolds vary
widely from soft gels, mainly serving as carriers for cells [4,5] to stiff
biodegradable calcium phosphate scaffolds [6,7]. Another criterion
to be fulfilled is the biocompatibility or in vivo biofunctionality. All
implant materials must be non-toxic to the body and prove to
interact properly with the host tissue.
Another quite important requirement is that the scaffold must
act as a three-dimensional (3D) template for in vitro and in vivo
tissue growth, i.e., the scaffold must consist of an interconnected
macroporous network allowing for cell/tissue growth and flow
transport of nutrients. In the case of bone tissue engineering, it was
shown [8,9] that the interconnections for bone ingrowth larger
than 50 mm were favourable for mineralized bone formation. The
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interconnectivity of the pores dominates the flow properties, which
are important to ensure adequate delivery of cells during seeding
and nutrients during subsequent culture/implantation. Several in-
vestigators [6,8,10,11] have also studied bone ingrowth into porous
material with different pore sizes and the consensus seems to be
that the optimal pore size for bone ingrowth is 100–400 mm
[6,8,10,11]. Therefore, an ideal scaffold would have interconnects of
at least 50 mm in diameter between its macropores of 100–400 mm
pore size range. It is thus important to be able to quantify both the
pores and interconnects to optimize tissue scaffolds.
Effective scaffold assessment techniques are then required right
at the initial stages of research and development to select or design
scaffolds with suitable properties. Micro-Computed Tomography
(micro-CT) appears to be such a measurement technique. Micro-CT
was identified as having various key advantages over other tech-
niques, such as its non-destructiveness and the possibility to assess
many different morphometric parameters [10–12]. This technique
was first proposed to analyze trabecular bone samples [13] and,
since then, has been used extensively in the study of trabecular
architecture, [14] and their applications in other areas are clearly
increasing, namely in the tissue engineering field. The increasing
use of this technique in tissue engineering [10–12] can be attrib-
uted to micro-CT capacity to provide for accurate quantitative and
qualitative information on the 3D morphology of the sample. An-
other main advantage is that the interior of the object can be
studied with great detail without physical sectioning or use of toxic
chemicals. Moreover, after scanning, the integral samples can be
subjected to other tests due to its non-destructive nature, thereby
resolving the problem of sample scarcity. This is a very important
characteristic allowing, for instance, the accurate study of bone
ingrowth which is being widely used by the group of Cancedda
[6,15]. The morphometric parameters for architectural analyses of
scaffolds can be easily extrapolated based on the histomorpho-
metric/structural indices usually measured for bone samples, such
as bone surface (BS) and volume (BV), trabecular thickness (Tb. Th)
and trabecular separation (Tb. Sp), structural degree of anisotropy
(DA) or bone surface-to-volume ratio (BS/BV) [16].
Different materials have been proposed to be used as both 3D
porous scaffolds and hydrogel matrices for distinct tissue engi-
neering strategies. It is often beneficial for the scaffolds to mimic
certain advantageous characteristics of the natural extracellular
matrix, or developmental or wound healing cascades [17]. Ideally,
scaffolds would be made of biodegradable polymers whose prop-
erties closely resemble those of the extracellular matrix (ECM),
a soft, tough, and elastomeric protein-rich network, that provides
mechanical stability and structural integrity to tissues and organs
[18]. Chitosan appears to be an excellent alternative due its in-
teresting and versatile properties [19,20]. Studies on chitosan as
a potential candidate for tissue engineering scaffolding demon-
strate this, as those have been clearly intensified during the past
years [19,20]. Chitosan is a natural polymer obtained from renew-
able resources, obtained from the shell of shellfish, and the wastes
of seafood industry. It has attractive properties such as bio-
compatibility, biodegradability, antibacterial, and wound healing
activity [20]. Furthermore, recent studies suggested that chitosan
and its derivatives are promising candidates to be used as sup-
portingmaterials for tissue engineering applications, owing to their
porous structure, gel forming properties, ease of chemical modifi-
cation, high affinity to in vivo macromolecules, and so on [19].
Bearing all these considerations in mind, the aim of the present
study was to evaluate the performance of chitosan-based scaffolds
produced by a particle aggregation method proposed for tissue
engineering applications. Those systems should try to meet the
three key requirements for an ideal design: a porous structure with
adequate morphological characteristics, adequate mechanical
behaviour and an in vivo biocompatibility. To evaluate these
properties, micro-Computed Tomography (micro-CT) was carried
out for accurate morphometric characterization and Dynamical
Mechanical Analysis (DMA) was performed to study the scaffolds
behaviour in wet state under compression solicitation. Chitosan
scaffolds were also evaluated in vivo using a rat muscle-pockets
model for different implantation periods (1, 2 and 12 weeks) with
subsequent characterization, including histological and immuno-
histochemical evaluation.
2. Materials and methods
2.1. Scaffolds production
The chitosan particle aggregated scaffolds were produced as described else-
where [21]. Briefly, chitosan (medium molecular weight and deacetylation degree
z85%) was grinded and dissolved overnight in acetic acid (1% vv) to obtain a chi-
tosan solution (2% wt). Unless otherwise stated, all chemicals were bought from
Sigma–Aldrich and used as received. After complete dissolution and filtration, the
prepared solutions were extruded through a syringe at a constant rate (10 ml/h) to
form chitosan droplets into a NaOH (1M) precipitation bath where particles with
regular diameter were formed. The residence time of the chitosan droplets in the
precipitation mediumwas minimized till the precipitation of chitosan particles. The
same residence time was further used to produce the chitosan particles and was
approximately 5 min. The chitosan particles were collected and washed repeatedly
with distilled water until neutral pH was reached. The particles were subsequently
placed into cylindrical moulds and left to dry at 60 #C for 3 days. No significant
compression force was applied other than to fit the particles into the mould ade-
quately. The drying temperature was optimized in order to accelerate the solvent
evaporation in a reasonable time period. Cylindrical shaped scaffolds with 8 mm
height and 5 mm diameter were obtained. For the in vivo studies, cylindrical shaped
scaffolds with 3 mm height and 5 mm diameter were used. Cross-sections of 10 mm
were also obtained from the scaffolds’ bulk and stained with eosin for visual
evaluation of the interface between the particles.
2.2. Micro-Computed Tomography (micro-CT)
Chitosan particle aggregated scaffolds (n¼ 3) were scanned using micro-Com-
puted Tomography (micro-CT) for morphological and morphometric characteriza-
tion. Micro-CT was carried out with a high-resolution micro-CT SkyScan 1072
scanner (Skyscan, Kontich, Belgium) using a resolution of pixel size of 8.79 mm and
integration time of 1.9 ms. The X-ray source was set at 70 keV of energy and 145 mA
of current. Approximately 400 projections were acquired over a rotation range of
180# with a rotation step of 0.45# . Data sets were reconstructed using standardized
cone-beam reconstruction software (NRecon v1.4.3, SkyScan). The output format for
each sample was 850 serial 1024%1024 bitmap images. Representative data sets of
200 slices were segmented into binary images with a dynamic threshold of 60–255
(grey values). This data was used for morphometric analysis (CT Analyser v1.5.1.5,
SkyScan) and to build 3D virtual models (ANT 3D creator v2.4, SkyScan). The mor-
phometric analysis included porosity, scaffolds interconnectivity, mean pore and
particle size and respective distribution. 3D virtual models of representative regions
in the bulk of the scaffolds were created, visualized and registered using both image
processing softwares CT Analyser and ANT 3D creator. In order to characterize the
porosity morphology of the scaffold, threshold inversion was used to create a 3D
model.
2.3. Dynamic Mechanical Analysis (DMA)
Dynamic Mechanical Analysis (DMA) was conducted in order to characterize the
dynamic mechanical behaviour of chitosan particle aggregated scaffolds inwet state
under dynamic compression solicitation. Chitosan cylindrical scaffolds were
immersed in Phosphate Buffer Solution (PBS) at physiological pH for 3 days for
complete hydration. The scaffolds were then subjected to compression cycles of
increasing frequencies ranging from 0.1 to 40 Hz with constant amplitude dis-
placements of 0.03 mm using a Tritec 2000 DMA (Triton Technology, UK). Experi-
ments were conducted at room temperature and five points were measured within
each decade. For each individual scaffold, the data is averaged over three consecu-
tive runs. Five samples were measured for each type of scaffolds. The real (storage
modulus), E0 , and the imaginary component (loss modulus), E00 , of the complex
modulus, E*¼ E0 þ iE00 (with i¼ (&1)1/2), were recorded against frequency. Reference
values for the compression modulus were collected at a frequency of 1 Hz.
2.4. In vivo biocompatibility study
2.4.1. Surgical procedure
Four male Sprague Dawley rats, weighing 350–380 g were used for in-
tramuscular implantation of the chitosan aggregated scaffolds. Each animal was
anaesthetized (induction with 3–3.5% isofluorane and 7 L/min of air for 2–3 min;
maintenance with intramuscular injection of 90 mg/kg of ketamin combined with
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5 mg/kg xylazine) and subjected to local tricotomy for adequate surgical procedure.
The skin was disinfected and under surgical sterile conditions, four lumbar para-
vertebral incisions of approximately 2 cm length were performed through the cutis,
subcutis and the panniculus carnosus (smooth skin muscle). After incising the fascia
of the latissimus dorsimuscle, craniolateral orientedmuscle-pockets were created by
blunt dissection. Into these pockets, the scaffolds were inserted and the fascia
carefully sutured, as well as the panniculus carnosus and finally the skin. As an
analgesic treatment, animals received Metamizol (200 mg/g of body weight per day
in drinking water ad libitum). At 1, 2 and 12 weeks post-implantation, the animals
were anaesthetized (see above) and sacrificed by an intracardial overdose of
pentobarbital. The scaffolds and surrounding tissue were explanted for further
evaluation. The animal experiment was approved by the local ethical authorities
responsible for animal experimentation.
2.4.2. Explants morphological characterization
At 1, 2 and 12 weeks post-implantation, explants were registered using ster-
eolight microscopy. Furthermore, micro-Computed Tomography (micro-CT) of the
explants was carried out as described previously. Two-dimensional X-ray photo-
graphs were registered from the bulk of the explants.
2.4.3. Histological evaluation
After explantation at 1, 2 and 12 weeks, samples were fixed in 4.7% formalin for
24 h and then kept in 70% ethanol. After fixation, samples were dehydrated in
graded ethanol (50, 70, 95 and 100%), cleared in xylene and then embedded in
paraffin. Afterwards, samples were sectioned in 2–4 mm sections and stained with
haematoxylin/eosin (H&E). The stained microscope slides were observed by, at least,
two independent observers.
2.4.3.1. Immunohistochemistry. In order to perform immunohistochemistry, paraf-
fin was removed from the samples slides upon heating. They were hydrated in
descending ethanol concentrations (100, 95, 70 and 50%) and incubated in phos-
phate buffer saline (PBS). The antigen retrieval was performed with microwave
incubation in citrate buffer (pH¼ 6) at 800W for 20min and the slides were washed
with PBS. The endogenous peroxidase was blocked with 1% hydrogen peroxide
(H2O2) in methanol, at room temperature (RT) for 15 min. After washing, the slides
were incubated with the primary antibodies at RT for 1 h (see Table 1) andwashed at
the end of the incubation period. Subsequently, the samples were incubated with
the secondary antibody (Polyclonal Swine Anti-Goat, Mouse, Rabbit Immunoglob-
ulins/Biotinylated – DakoCytomation, Denmark; dilution 1:100) at RT, for 30 min.
After washing with PBS, the samples were incubated with the ABComplex (Strept-
ABComplex/HRP, DakoCytomation, Denmark) at RT for 30 min and washed again
after the incubation period. Visualisation of the bound antibodies in the samples was
revealed by incubation with AEC substrate (Dako RealTM EnVisionTM Detection
System, Peroxidase/DABþ, Rabbit/Mouse; DakoCytomation, Denmark) until the
colour could be detected. The revelation of the labelling was stopped with PBS and
the samples were stained with Mayer’s Haematoxylin for nuclear contrast, at RT for
2 min. After this, the samples were washed with distilled water, dehydrated in
graded ethanol (50, 70, 95 and 100%), cleared with xylene substitute, permanently
mounted with Clarion" Mounting Medium, and observed in the light microscope
by, at least, two independent observers.
3. Results
3.1. Morphometric analysis
With the emerging of the advances on computer technology,
micro-CT has become a powerful tool for analyzing porous mate-
rials based on 3D geometrical considerations. Micro-CT can provide
virtual representations and accurate morphometric parameters of
structural characteristics in a non-destructive and reproducible
way that generates precise three-dimensional (3D) measurements
of scaffold architecture [11,12]. One of the key parameters of micro-
CT that one has to define is the threshold that is the basis for an
adequate morphometric analysis. In Fig. 1, we represent a charac-
teristic histogram for chitosan particle aggregated scaffolds that
allows us to define the dynamic threshold used for further mor-
phometric analysis and 3D models generation.
Quantitative analysis of the scaffolds architecture such as po-
rosity or pore size distribution can be obtained by micro-CT based
on the structural indexes usually measured for bone samples [14].
Scaffold (bone) volume (BV) is calculated using tetrahedrons cor-
responding to the enclosed volume of the triangulated surface [16].
Total volume (TV) is the overall volume of the scanned scaffold.
Scaffolds porosity (%) can, therefore, be calculated as (1&BV/TV).
Particle size (trabecular thickness) or pore diameter (trabecular
separation) as well as their distribution can also be computed.
Furthermore, interconnectivity can also be calculated using an
appropriate pore size limit. The referred values can be computed as
an average of all the 2D measurements giving information of the
Table 1
Primary antibodies used in the immunohistochemistry evaluation of the explants
Antibody Recognizes Dilution Incubation/
temperature
Company Country
CD18 Rat b2 integrins
(bchain of LFA-1)
1:100 1 h/RT Serotec UK
CD3 T lymphocytes 1:30 1 h/RT DakoCytomation Denmark
vWF von Willebrand factor 1:200 1 h/RT DakoCytomation Denmark
SMA Smooth muscle actin 1:5000 1 h/RT Sigma USA
Fig. 1. Representative histogram obtained for chitosan particle aggregated scaffolds used to define the dynamic threshold (grey values).
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parameters behaviour along the scaffolds (such as porosity distri-
bution) or more accurately in 3D analysis, as performed in the
present paper.
Porosityand interconnectivityof the chitosanparticle aggregated
scaffolds were also computed. Percentage values of 27.78! 2.80%
and 94.99!1.41% (mean! SD) were found for both parameters,
respectively. It is important to stress out that interconnectivity was
calculated with a limit in pore size of 53 mm as minimum value for
interconnected pores, meaning that interconnection diameters
lower than this value were consider as closed pores.
The average particle size was 430.72! 54.42 mm and the aver-
age pore diameter was 265.46! 24.27 mm and their distribution is
disclosed in Fig. 2. By analysing the pore size distribution, one can
observe that the chitosan-based scaffolds present a heterogeneous
range of pore size covering the optimal pore size reported as
consensus for tissue engineering applications [6,8,10,11].
3.2. Dynamic Mechanical Analysis (DMA)
As previously discussed, one of the key issues of scaffolds design
for tissue engineering is their mechanical performance. Therefore,
the assessment of scaffolds’ mechanical behaviour is essential to
ensure the mechanical stability, namely in hydrated state
approaching the in vivo condition where physiological fluids are
present. In the present paper, chitosan particle aggregated scaffolds
were characterized in the wet state over a range of physiological
frequency range in load-bearing applications, such as articular
cartilage or bone [22,23]. The reference values at a frequency
of 1 Hz for elastic (storage) and viscous (loss) components of
the complex modulus were found to be 4.21!1.04 MPa and
0.36! 0.07 MPa (mean! SD), respectively. The storage (E0) and loss
(E00) modulus behaviour for increasing frequencies is presented in
Fig. 3 and the frequency dependence of the loss factor (tan d) is
Fig. 2. Particle (A) and pore (B) size distribution of chitosan particle aggregated scaffolds assessed by 3D micro-CT analysis.
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shown in the inset graph. As it is possible to observe, the elastic
modulus (E0) increases with increasing frequency, being typically
above 4 MPa, while the viscous modulus (E00) shows the inverse
trend with a slight increase for higher frequencies. As a conse-
quence, there is an obvious decrease of the loss factor, (tan d¼ E00/
E0) with increasing frequency with a slight increase for higher
frequencies as shown in the inset graph.
3.3. In vivo biocompatibility
No systemic or regional surgical complications were seen for
any of the rats in the post-operative period. A morphological
characterization of the explants, after the different implantation
periods, showed connective tissue ingrowth into the chitosan
scaffolds even after 1 week of implantation (Fig. 4). This tissue
ingrowth becomes more pronounced with increasing time periods
of implantation. This was further confirmed by micro-CT. The 2D
X-Ray evaluation of the cross-sections in the explants’ bulk is
presented in Fig. 5 where it is possible to identify the increase of the
host tissue inside the scaffolds pores with the implantation time.
Furthermore, there is a macroscopic indication of vascularization of
the implants after 12 weeks of implantation (Fig. 4E and F).
Histology, including immunohistochemistry analysis, was per-
formed after the different implantation periods, and the obtained
results are disclosed in the following Figs. 6–10. After 1-week im-
plantation of the chitosan particle aggregated scaffolds, the pre-
dominant inflammatorycell type foundwas thepolymorphonuclear
neutrophil (PMNs) recruited from the circulation in response to the
implantedmaterial (Fig. 6A). Some other inflammatory cells, such as
lymphocytes and macrophages can also be observed, but in a less
extent compared with the PMNs. In addition, the recruited PMNs
were labelled by anti-CD18, which has affinity with the integrins,
binding to the surface of recruited leukocytes (Fig. 7B). The lym-
phocytes present in the histological samples were labelled by
Fig. 3. Dynamic mechanical analysis of chitosan particle aggregated scaffolds in wet state showing the storage (E0) and loss (E00) modulus behaviour for increasing frequencies under
dynamic compression solicitation. The inset graph shows the frequency dependence of the loss factor (tan d).
Fig. 4. Chitosan particle aggregated explants after (A) and (B) 1 week, (C) and (D) 2 weeks, and (D)and (E) 12 weeks after implantation using stereolight microscopy at different
magnifications.
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anti-CD3 (specific for the T lymphocytes subset) and shown to be
residual when compared to PMNs (Fig. 8B). Few new blood vessels
could be found at this stage (Figs. 9B and 10B), in spite of the ex-
pression of vWF at this time of implantation which is a common
endothelial marker during the angiogenic process [24]. In addition,
it is possible to identify a rudimentaryextracellularmatrix produced
in the pores of the chitosanparticle aggregated scaffolds, although it
is still much disorganized (Figs. 6A and 10B).
After 2 weeks of implantation, the main inflammatory cells
present were shown to be lymphocytes (Fig. 6B), which was con-
firmed with their specific labelling (Fig. 8C). Some remaining PMNs
could still be observed (Fig. 7C), as well as some foreign body giant
cells, resulting from the fusion of macrophages trying to phagocyte
the implant (Fig. 6.B). Although some necrosis can be observed in
the periphery of the implant (Fig. 6B), it can be neglected if com-
pared with the amount of extracellular matrix formed around the
particles of the scaffold (Figs. 6B and 10C), which shows a more
organized structure compared with 1 week of implantation. Fur-
thermore, the presence of smooth muscle actin is more evident
(Fig. 10C), and allows to say that, the connective tissue is growing
and the neo-vascularization is also increasing between the particles
of the scaffold. This fact is further supported by the expression of
vWF at this implantation period (Fig. 9C).
Three months after the implantation of the chitosan particle
aggregated scaffolds, some of the remaining PMNs showed to be
apoptotic (Fig. 6C) and the spaces between the particle of the
scaffolds are, in this stage, filled with connective tissue cells
(Fig. 6C). It was possible to observe that the PMNs appeared in
much less amount compared with the other implantation times
(Fig. 7D). Some lymphocytes are, as well, still present in the in-
filtrate (Fig. 8D). Furthermore, the general expression of vWF
observed at 1 week of implantation due to the initially formed clot
is now less evident, being much more restricted to the vascularized
tissue (Fig. 9D). At this stage of implantation it is clear that the
extracellular matrix shows to be much more organized along and
between the particles of the scaffold (Figs. 6C and 10D). Further-
more, the neo-vascularization already observed in earlier times of
implantation increased as the SMA labelling shows in the newly
formed blood vessels (Fig. 10D). These features demonstrate that
the scaffolds were well tolerated by the host and the ingrowth of
host connective tissue into the scaffolds structure is an evidence
of good integration.
4. Discussion
4.1. Morphometric analysis
For tissue engineering applications, it is important to ensure
that the scaffold has an adequate architecture in order to allow for
optimal cell migration and nutrients supply to assure optimal tissue
growth in an in vivo situation. In order to be able to assess these
morphometric requirements, micro-CT is becoming a powerful tool
to compare scaffold production techniques [11,12]. Direct micro-CT
based imaging analysis is non-destructive and non-invasive and
allows precise 3D measurements of scaffold architecture quanti-
fying scaffold porosity, surface area, and 3D measures such as
Fig. 5. Representative 2D X-ray microphotographs obtained by micro-CT of the bulk chitosan particle aggregated explants after 1 (A) and 12 (B) weeks after implantation clearly
showing the tissue ingrowth indicated by the arrows.
Fig. 6. Representative H&E stained histological sections of tissues surrounding chitosan-based implants after (A) 1 week, (B) 2 weeks and (C) 12 weeks of intramuscular im-
plantation. PMN – polymorphonuclear neutrophil, MØ – macrophage, and Lym – lymphocyte. Bar scale: 20 mm.
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interconnectivity, pore size and distribution, and pore wall thick-
ness providing valuable knowledge to optimize scaffold design.
These combined advantages over other morphological character-
ization techniques are well discussed in a review by Ho and
Hutmacher [12] and, in our opinion, clearly justify why micro-CT
has become a very popular technique for characterizing porous
scaffolds [12,16] or bone ingrowth [10,11]. As a result, this meth-
odology is very useful for quality control of scaffold fabrication
processes and all data obtained for computational models will be
helpful in further analyses, in order to improve our understanding
of mechanical and biochemical stimuli on tissue formation.
In the present work, due to the above mentioned advantages,
micro-CT was used to assess the morphometric relevant parame-
ters and 3D reconstructions of porous structures allowing to
visualize the internal cellular structure. Particle aggregation
methodology allows for the production of suitable scaffolds for
load-bearing bone applications. Trabecular bone typically consists
of 30% bone tissue and 70% void volume [14]. Our effort was to
fabricate scaffolds by the particle aggregation that should have
a total pore volume similar to the percent bone, as previously
reported [21]. It is expected that as an in vivo bone defect heals,
bone tissue grows into the porous system of the scaffold, and the
scaffold itself degrades completely (allowing for 30% ingrowth) to
obtain healing of the bone defect. The chitosan scaffolds produced
by this methodology have pore volumes of approximately 30% as
discussed before. Furthermore, and using threshold inversion, mi-
cro-CT allows to visualize the pores network giving a clear image of
scaffolds’ porositymorphologywhich resemble the bone trabecular
structure, as shown in Fig. 11.
One can still consider that the porosity value is low for the
typical reported requirements for tissue engineering scaffolding
[1,2]. But we have to consider that there is also the compromise
between porosity and mechanical behaviour. Since the scaffolds
present a high interconnectivity degree, the mechanical perfor-
mance appears as more critical when aiming at load-bearing tissue
engineering applications, such as bone and cartilage. Furthermore,
pore size is another important factor for tissue ingrowth. Several
researchers have studied bone ingrowth into porous material with
different pore sizes [6,8,10,11] and the consensus seems to be that
the optimal pore size for bone ingrowth is 100–400 mm [6,8,10,11].
The proposed scaffolds have shown to present a pore size distri-
bution in the range of the optimal pore size (Fig. 2). The 3D struc-
tures present pores with irregular shape and heterogeneous sizes
(Fig. 11) because pores are created by the interstices between the
particles after aggregation. Again, the pore morphology resembles
those in trabecular bone where trabaculae are irregular in shape
and size.
Another key issue on tissue engineering scaffolding is the
interconnectivity which has direct implications for cell growth, cell
migration, flow of nutrients and tissue growth into scaffolds. The
proposed scaffolds are highly interconnected (Fig. 11) to assure
these biological requirements. For instances, Lu et al. [9] reported
the importance of interconnections for bone ingrowth and showed
that interconnections larger than 50 mm were favourable for min-
eralized bone formation. This value, thought to be the minimum
pore size for good tissue ingrowth, is also been considered in the
study by Otsuki et al. [10] and, for that reason, was used to calculate
the interconnectivity values in the present study, meaning that the
interconnectivity only considers pore interconnections higher than
53 mm. If the pore interconnection is lower than 53 mm it is con-
sidered as a close pore. In general, this limit is not considered or at
least is not reported in the majority of published morphometric
studies and it is of major importance since it can change signifi-
cantly the values of interconnectivity as shown in Table 2. If we
used a lower value in the limit of pore size, the interconnectivity
clearly increase, as disclosed in Table 2. Nevertheless, the
Fig. 7. Representative CD18 immunostained sections of tissues surrounding chitosan-based implants after (B) 1 week, (C) 2 weeks, and (D) 12 weeks of intramuscular implantation.
(A) Negative control. PMN – polymorphonuclear neutrophil, and R Leuk – recruited leukocytes. Bar scale: 20 mm.
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interconnectivity with low pore interconnection values will show
no relevance when translated to in vivo situations, because the
minimum pore size considered will not promote adequate tissue
ingrowth. The results of the micro-CT analysis implied that the
scaffolds have a suitable architecture for tissue engineering
applications.
4.2. Dynamic Mechanical Analysis (DMA)
The maintenance of sufficient structural integrity of scaffolds is
critical in tissue engineering applications, more so since the cell and
tissue remodelling is important for achieving stable biomechanical
conditions at the host site. Additionally, in the case of load-bearing
tissue such as articular cartilage and bone, the scaffold matrix must
provide sufficient temporary mechanical support to withstand in
vivo stresses and loading [1,3,12]. Previous work [21] has shown
that chitosan scaffolds produced under the same conditions, with
the same percentage porosity as the scaffolds used in this study had
a compressive modulus of 132! 7 MPa in dry state under static
compression solicitation. The scaffolds showed a very good me-
chanical behaviour when compared to the typical mechanical
properties obtained for chitosan-based porous materials even if in
composite form [25,26]. The relatively high mechanical properties
obtained by the particle aggregation methodology was further
supported byotherworks, namely thework by Jiang et al. [27]when
using chitosan microspheres in this case with poly(lactic acid–
glycolic acid) sintered together to obtain the final 3D structure.
Nevertheless, it is common to study the scaffolds mechanical
performance in dry state and static conditions. In the present study,
we have evaluated the mechanical performance of the chitosan
particle aggregated scaffolds in hydrated state under dynamic
solicitation, mimicking in this way the in vivo physiological condi-
tion in a post-implantation scenario. The dynamic mechanical
behaviour of the scaffolds was characterized by DMA. Both storage
and loss modulus (E0 and E00) weremeasured in the frequency range
0.1–40 Hz, which are typical frequencies found in physiological
situations in load-bearing applications [22,23]. The storage modu-
lus (E0) is about one order of magnitude higher than the loss
modulus (E00) indicating an elastic nature of the chitosan scaffolds
in the hydrated state. The storage modulus increases with in-
creasing frequency E0 while the loss modulus shows the inverse
tendency except for high frequencies. This results in a decrease of
the tan d (loss factor) with increasing frequency with a small in-
crease for high frequencies (inset graphic in Fig. 3). This factor
measures the proportion of the imposed mechanical stress that is
dissipated in the form of heat. As tan d is typically above 0.08 for
f< 1 Hz, one may conclude that the scaffolds possesses significant
damping capability that may be useful to dissipate some cyclic
mechanical energy that is imposed in an implantation scenario.
Nevertheless, there is an increase in E00 for high frequencies, which
suggests that the material exhibits some dissipation capability for
high frequencies. The developed scaffolds present elastic and vis-
cous modulus of 4.21!1.04 MPa and 0.36! 0.07 MPa, respectively,
at a frequency of 1 Hz. The obtained compression modulus in wet
state of the scaffolds produced by the particle aggregation method
presents considerable higher values when compared to other chi-
tosan-based scaffolds with fibre-based architectures produced by
fibre bonding which present a higher porosity [28]. Furthermore, it
is important to keep inmind that themechanical properties may be
further improved if desired with crosslinking or by incorporating
a ceramic filler.
The relatively good mechanical performance of the chitosan
particle aggregated scaffolds is attributed to the stable interface
between the chitosan particles as shown in the 3D virtual model
obtained by micro-CT (Fig. 12). The 3D virtual model shows the
bonding between the adjoining chitosan particles achieved by
Fig. 8. Representative CD3 immunostained sections of tissues surrounding chitosan-based implants after (B) 1 week, (C) 2 weeks, and (D) 12 weeks of intramuscular implantation.
(A) Negative control. Lym – lymphocyte. Bar scale: 20 mm.
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Fig. 9. Representative vWF immunostained sections of tissues surrounding chitosan-based implants after (B) 1 week, (C) 2 weeks, and (D) 12 weeks of intramuscular implantation.
(A) Negative control. BC – Blood Clot, and BV – blood vessel. Bar scale: 20 mm (A, B) and 50 mm (C, D).
Fig. 10. Representative SMA immunostained sections of tissues surrounding chitosan-based implants after (B) 1 week, (C) 2 weeks, and (D) 12 weeks of intramuscular implantation.
(A) Negative control. BV – blood vessel. Bar scale: 20 mm (A, B) and 50 mm (C, D).
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particle aggregation method process. This was achieved due to the
bioadhesive character of the chitosan polymer that resulted in
the merging of adjacent particles at their contact points to form the
chitosan porous 3D matrices. The cross-sections from the scaffolds’
bulk stained with eosin (Fig. 13) showed clearly the bonding areas
on the particle surfaces. This chitosan particles bonding leads to
a very stable interface between the particles which assures the
mechanical integrity and stability of the developed scaffolds.
4.3. In vivo biocompatibility
The non-cytotoxic behaviour of the chitosan particle aggregated
scaffolds was evaluated in previous studies [21]. In vitro tests
showed that the chitosan particle aggregated scaffolds were not
cytotoxic to L929 fibroblast cell line and to human adipose stem
cells [21]. However, it is critical to evaluate the scaffolds’ perfor-
mance in an in vivo environment when proposing scaffolds to be
used in biomedical applications, namely tissue engineering. In vivo
parameters such as inflammatory response, tissue ingrowth, vas-
cularization potential and overall host response gives the correct
evidence to consider the biofunctionality of scaffolds. This is one of
the obvious key requirements for tissue engineering applications.
After intramuscular implantation of the developed scaffolds, no
systemic or regional surgical complications were seen in any of the
rats. Under optical microscopy it is clear that the chitosan scaffolds
architecture allowed for tissue ingrowth, being the feature more
evident for longer periods of implantation (Figs. 4 and 5). Micro-CT
also allowed assessing the increase of spatial and temporal tissue
ingrowth into the scaffolds, as shown in the 2DX-ray cross-sections
from the bulk of the implants (Fig. 5). The increase in the connective
tissue ingrowth provides a clear evidence that the interconnectivity
of the developed scaffolds plays a key role in this process. The in-
fluence of interconnectivity on the tissue ingrowth was already
demonstrated by Otsuki et al. [10] by studying the effect of narrow
pore throats on bone and tissue differentiation using bioactive
porous titanium implants and micro-CT. The study revealed that
narrow pore throats (e.g., low interconnectivity with low pore size
limitation for its calculation) were inhibiting tissue differentiation
in pores [10].
There is also a clear macroscopic indication of the presence of
a vascularized tissue after 12 weeks of implantation that was
further confirmed by the immunohistochemistry analyses. Again,
scaffolds interconnectivity seems to be favourable for a good
integration of the scaffolds in the host tissue, promoting the vas-
cularization of the scaffolds which is critical in tissue engineering
applications for cell growth, tissue ingrowth and nutrients flow. For
tissue differentiation, vascularization is an important factor, and
narrow pore interconnectivity may inhibit adequate vasculariza-
tion [10].
After implantation of a medical device such as a biomaterial, the
host tissue will inevitably be traumatized by the implantation
procedure [29,30] triggering an inflammatory response. An in-
flammatory response triggered by chitosan particle aggregated
scaffolds was observed after 1, 2 and 12 weeks of intramuscular
implantation in rats. One week after the implantation of the chi-
tosan particle aggregated scaffolds, PMNs were the predominant
inflammatory cell type (Figs. 6A and 7B). These cells are normally
recruited from blood circulation whenever there is tissue damage
and the initiation of the process of wound healing. In less extent,
lymphocytes (Fig. 8B) and macrophages (Fig. 6A) were observed,
following again the typical features of the implantation of foreign
bodies [29,30]. The type of inflammatory infiltrate found in the
surrounding tissue of the implanted chitosan particle aggregated
scaffolds is the type of infiltrate expected when a foreign body is
Fig. 11. 3D virtual models of chitosan particle aggregated scaffolds (A) showing the gradual transition (B, C) till the inverse 3D model (D) evidencing the porosity morphology.
Table 2
Interconnectivity calculated with different voxels size
Limit voxels Limit voxel
size (mm)¼ pore size
Interconnectivity (%)
(mean! SD)
2 17.58 99.27! 0.89
4 35.16 96.52! 1.55
6 52.74 94.99! 1.41
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implanted in a host [29,30], showing a normal and mild in-
flammatory reaction towards the implants. Few new blood vessels
can be found at this stage (Figs. 9B and 10B). The neo-vasculariza-
tion observed at this stage identified by the vWF expression
(Fig. 9B) is due to the initially formed clot in part to the in-
flammatory process that brings the leukocytes in circulation to the
site of implantation after the surgical procedure. Even though, it is
considered very important for the nutrition of the new tissue that is
expected to grow in the spaces between the particles forming the
scaffold.
In contrast with the 1 week of implantation, after 2 weeks, the
principal cell type in the scaffold and surrounding tissue were
without any doubt lymphocytes. These cells start to appear when
the acute inflammation progresses to chronic inflammation, around
the 2nd week after the tissue injury and if the damaging agent
persists in the site [31].When the implant has dimensionswhich the
phagocytic cells are not able to phagocytose and the macrophages
may fuse, forming foreign body giant cells [32]. Therefore, the ob-
served reaction coincides with the patterns of a mild foreign body
reaction [32]. The initially formed clot (resulting from the implan-
tation procedure and consequent cascades of events for wound
healing) is now less evident (Fig. 9C).
After 12 weeks in the intramuscular environment, some foreign
body giant cells were observed near the implanted particle aggre-
gated chitosan scaffolds. Although some PMNs and lymphocytes
were observed, the type of reaction showed to be non-granulo-
matous [33]. This type of inflammatory infiltrate, where mono-
nuclear cells clearly predominate, is quite typical for foreign body
reactions [32] and shows a normal response from the host to the
chitosan particle aggregated scaffolds [32].
The neo-vascularization of the spaces between the particle
forming the chitosan-based scaffolds was also achieved (Figs. 9 and
10). One week after implantation, few new blood vessels were
observed, responsible for the recruitment of leukocytes to the site
of implantation. In early stages of inflammation and wound healing
process, neo-vascularization is an important feature, since it allows
the adequate nutrition of the new connective tissue that will grow
around and between the scaffold structure. With the increasing
need of nutrition, justified by the increase of extracellular matrix
formation, the density of vascularization increased as well after 2
and 12 weeks of implantation. After these periods of implantation,
it was possible to observe that the scaffolds induced a marked
angiogenic response promoted also by the high scaffolds inter-
connectivity (Figs. 9C, D, and 10C, D).
The neo-vascularization of the implants created by new blood
vessels formationwas clear even after only 2weeks of implantation,
becoming more significant as the implant remained for a longer
period of time, showing that the scaffolds characteristics were
favourable to the integration in the host tissue. These blood vessels
established and developed as seen for 12 weeks after scaffolds
implantation. In fact, the vascularization is another critical factor for
a successful approach in tissue engineering. The chitosan scaffold
architecture has shown its ability to allow for cells ingrowth, and
subsequent migration into and through the matrix. This was
accomplished given that the 3Dmaterials enabled themass transfer
of nutrients and metabolites, and provided sufficient space for
development and later remodelling of the organized tissue.
The formation of blood vessels developing inside the scaffold
was a remarkable result since no angiogenic growth factor or pre-
viously seeded angiogenic cells were used in this study. This kind of
evidence leads one to speculate that the good in vivo performance
of the chitosan-based scaffolds produced by particle aggregation
can be still further improved by using any angiogenic growth factor
or cells important in vasculature. These results were also observed
by Ehrenfreund-Kleinman et al. [34] for chitosan/arabinogalactan-
based sponges where the vascularization became clearer for 11
Fig. 12. 3D virtual models of chitosan particle aggregated scaffolds evidencing the interface between the particles.
Fig. 13. Cross-sections of chitosan particle aggregated scaffolds stained with eosin showing the particles’ interface indicated by the arrows.
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weeks of implantation period as detected by light microscopy and
magnetic resonance imaging. The generation of extracellular ma-
trix by the connective tissue cells between the spaces of the particle
aggregated chitosan scaffolds was also identified (Fig. 6C). Fur-
thermore, the immunolabelling of smooth muscle actin (SMA)
allowed, at the same time, for the observation of vessels’ ingrowth,
since it is one of the constituents of the vessel’s walls. At 1 week of
implantation, it was possible to observe some extracellular matrix
form a still disorganized network between the particles of the
scaffold (Fig. 6A). This network increased the amount of extracel-
lular matrix and organization along the time of implantation. These
overall features show that the implanted particle aggregated
chitosan scaffolds are well tolerated by the host. Furthermore, it
was shown that the scaffolds architecture, namely pore inter-
connectivity, is favourable for cell ingrowth and subsequent
production of extracellular matrix by the connective tissue cells.
The overall host response elicited by the intramuscular im-
plantation of chitosan particle aggregated scaffolds was a mild and
expected inflammatory response. It started with the normal acute
inflammation initiated by the surgical procedure of implantation,
noticed at the first week progressing to the normal chronic in-
flammation usually observed in the implantation of foreign bodies
[31,32]. The increasing of neo-vascularization, as well as the pres-
ence of smooth muscle actin and the enhanced organization of the
extracellular matrix with the time of implantation, demonstrates
the good integration and scaffolds’ biofunctionality. The high
interconnectivity of the developed chitosan particle aggregated
scaffolds might also play a key role in the scaffold integration with
vascularization from the host tissue.
5. Conclusions
In this study, wemanage to fabricate chitosan scaffolds based on
a particle aggregation technique. These scaffolds have shown to
fulfill three main key requirements for tissue engineering scaffold-
ing: morphological adequacy, mechanical stability and in vivo
functional biocompatibility. Micro-CT allowed for an accurate mor-
phometric characterization showing that the developed scaffolds
had an adequate pore size range and an interconnected porous
structure assuming a relevant interconnection limit. Furthermore,
porosity morphology will allow for tissue ingrowth resembling
those of trabecular bone, if this application is considered. In addition
to all this, the mechanical properties demonstrated the scaffolds
stability and suitability for load-bearing bone tissue engineering
applications. From a biological point of view, it is possible to con-
clude that the chitosan particle aggregated scaffolds are suitable
structures to allow tissue ingrowth with an induced minimal
inflammatory response by the host in an intramuscular site. Fur-
thermore, neo-vascularization, aswell as the enhancedorganization
of the extracellular matrix, with the implantation time confirms the
scaffolds’ biofunctionality. It is concluded that chitosan scaffolds
produced by a particle aggregationmethodology aremorphological
and mechanically adequate for their aimed applications, with
demonstrated in vivo functionality. Consequently, they are without
doubts potential candidates for being used in load-bearing tissue
engineering applications.
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